# PC Connection Inc: financial statements, quarterly

CNXN · Nasdaq · CIK 1050377 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cnxn.md) · [Financials](/companies/cnxn/financials.md) · [Filings](/companies/cnxn/filings.md) · [Insiders](/companies/cnxn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cnxn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [693](/filings/0001558370-24-013946.md) | [696 d](/filings/0001104659-26-019108.md) | [632](/filings/0001558370-25-005995.md) | [736](/filings/0001558370-25-009797.md) | [725](/filings/0001104659-25-103731.md) | [709 d](/filings/0001104659-26-019108.md) | [701](/filings/0001104659-26-051493.md) | [760](/filings/0001104659-26-088136.md) | [709](/filings/0001104659-25-103731.md) | [703 d](/filings/0001104659-26-019108.md) | [722](/filings/0001104659-26-051493.md) | [854](/filings/0001104659-26-088136.md) |
| Cost of revenue | $m | [561](/filings/0001558370-24-013946.md) | [567 d](/filings/0001104659-26-019108.md) | [514](/filings/0001558370-25-005995.md) | [600](/filings/0001558370-25-009797.md) | [589](/filings/0001104659-25-103731.md) | [579 d](/filings/0001104659-26-019108.md) | [574](/filings/0001104659-26-051493.md) | [622](/filings/0001104659-26-088136.md) | [570](/filings/0001104659-25-103731.md) | [567 d](/filings/0001104659-26-019108.md) | [589](/filings/0001104659-26-051493.md) | [697](/filings/0001104659-26-088136.md) |
| Gross profit | $m | [132](/filings/0001558370-24-013946.md) | [130 d](/filings/0001104659-26-019108.md) | [118](/filings/0001558370-25-005995.md) | [137](/filings/0001558370-25-009797.md) | [135](/filings/0001104659-25-103731.md) | [130 d](/filings/0001104659-26-019108.md) | [127](/filings/0001104659-26-051493.md) | [138](/filings/0001104659-26-088136.md) | [139](/filings/0001104659-25-103731.md) | [136 d](/filings/0001104659-26-019108.md) | [133](/filings/0001104659-26-051493.md) | [157](/filings/0001104659-26-088136.md) |
| Selling, general and administrative | $m | [99.8](/filings/0001558370-24-013946.md) | [102 d](/filings/0001104659-26-019108.md) | [105](/filings/0001558370-25-005995.md) | [105](/filings/0001558370-25-009797.md) | [105](/filings/0001104659-25-103731.md) | [107 d](/filings/0001104659-26-019108.md) | [110](/filings/0001104659-26-051493.md) | [107](/filings/0001104659-26-088136.md) | [108](/filings/0001104659-25-103731.md) | [109 d](/filings/0001104659-26-019108.md) | [109](/filings/0001104659-26-051493.md) | [114](/filings/0001104659-26-088136.md) |
| Operating income | $m | [32.0](/filings/0001558370-24-013946.md) | [27.9 d](/filings/0001104659-26-019108.md) | [13.5](/filings/0001558370-25-005995.md) | [30.9](/filings/0001558370-25-009797.md) | [30.0](/filings/0001104659-25-103731.md) | [22.6 d](/filings/0001104659-26-019108.md) | [14.5](/filings/0001104659-26-051493.md) | [30.9](/filings/0001104659-26-088136.md) | [30.3](/filings/0001104659-25-103731.md) | [23.6 d](/filings/0001104659-26-019108.md) | [20.2](/filings/0001104659-26-051493.md) | [43.0](/filings/0001104659-26-088136.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [9.1](/filings/0001558370-24-013946.md) | [8.3 d](/filings/0001104659-26-019108.md) | [4.9](/filings/0001558370-25-005995.md) | [9.4](/filings/0001558370-25-009797.md) | [9.5](/filings/0001104659-25-103731.md) | [6.6 d](/filings/0001104659-26-019108.md) | [5.0](/filings/0001104659-26-051493.md) | [9.3](/filings/0001104659-26-088136.md) | [9.2](/filings/0001104659-25-103731.md) | [6.5 d](/filings/0001104659-26-019108.md) | [6.4](/filings/0001104659-26-051493.md) | [12.4](/filings/0001104659-26-088136.md) |
| Net income | $m | [25.6](/filings/0001558370-24-013946.md) | [23.8 d](/filings/0001104659-26-019108.md) | [13.2](/filings/0001558370-25-005995.md) | [26.2](/filings/0001558370-25-009797.md) | [27.1](/filings/0001104659-25-103731.md) | [20.7 d](/filings/0001104659-26-019108.md) | [13.5](/filings/0001104659-26-051493.md) | [24.8](/filings/0001104659-26-088136.md) | [24.7](/filings/0001104659-25-103731.md) | [20.7 d](/filings/0001104659-26-019108.md) | [17.2](/filings/0001104659-26-051493.md) | [33.2](/filings/0001104659-26-088136.md) |
| Diluted EPS | $ per share | [0.97](/filings/0001558370-24-013946.md) | not reported | [0.50](/filings/0001558370-25-005995.md) | [0.99](/filings/0001558370-25-009797.md) | [1.02](/filings/0001104659-25-103731.md) | not reported | [0.51](/filings/0001104659-26-051493.md) | [0.97](/filings/0001104659-26-088136.md) | [0.97](/filings/0001104659-25-103731.md) | not reported | [0.68](/filings/0001104659-26-051493.md) | [1.31](/filings/0001104659-26-088136.md) |
| Basic EPS | $ per share | [0.97](/filings/0001558370-24-013946.md) | not reported | [0.50](/filings/0001558370-25-005995.md) | [0.99](/filings/0001558370-25-009797.md) | [1.03](/filings/0001104659-25-103731.md) | not reported | [0.52](/filings/0001104659-26-051493.md) | [0.98](/filings/0001104659-26-088136.md) | [0.98](/filings/0001104659-25-103731.md) | not reported | [0.68](/filings/0001104659-26-051493.md) | [1.31](/filings/0001104659-26-088136.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [241](/filings/0001558370-23-017247.md) | [145](/filings/0001558370-25-001382.md) | [148](/filings/0001558370-24-006387.md) | [128](/filings/0001558370-24-010484.md) | [168](/filings/0001558370-24-013946.md) | [178](/filings/0001104659-26-019108.md) | [182](/filings/0001558370-25-005995.md) | [187](/filings/0001558370-25-009797.md) | [188](/filings/0001104659-25-103731.md) | [193](/filings/0001104659-26-088136.md) | [196](/filings/0001104659-26-051493.md) | [124](/filings/0001104659-26-088136.md) |
| Current assets | $m | [1,041](/filings/0001558370-23-017247.md) | [1,049](/filings/0001558370-25-001382.md) | [1,023](/filings/0001558370-24-006387.md) | [1,148](/filings/0001558370-24-010484.md) | [1,152](/filings/0001558370-24-013946.md) | [1,167](/filings/0001104659-26-019108.md) | [1,117](/filings/0001558370-25-005995.md) | [1,139](/filings/0001558370-25-009797.md) | [1,174](/filings/0001104659-25-103731.md) | [1,221](/filings/0001104659-26-088136.md) | [1,291](/filings/0001104659-26-051493.md) | [1,294](/filings/0001104659-26-088136.md) |
| Total assets | $m | [1,181](/filings/0001558370-24-013946.md) | [1,188](/filings/0001558370-25-001382.md) | [1,161](/filings/0001558370-25-005995.md) | [1,283](/filings/0001558370-25-009797.md) | [1,286](/filings/0001104659-25-103731.md) | [1,299](/filings/0001104659-26-019108.md) | [1,248](/filings/0001104659-26-051493.md) | [1,269](/filings/0001104659-26-088136.md) | [1,306](/filings/0001104659-25-103731.md) | [1,351](/filings/0001104659-26-088136.md) | [1,425](/filings/0001104659-26-051493.md) | [1,428](/filings/0001104659-26-088136.md) |
| Current liabilities | $m | [340](/filings/0001558370-23-017247.md) | [328](/filings/0001558370-25-001382.md) | [290](/filings/0001558370-24-006387.md) | [389](/filings/0001558370-24-010484.md) | [367](/filings/0001558370-24-013946.md) | [371](/filings/0001104659-26-019108.md) | [354](/filings/0001558370-25-005995.md) | [368](/filings/0001558370-25-009797.md) | [384](/filings/0001104659-25-103731.md) | [420](/filings/0001104659-26-088136.md) | [477](/filings/0001104659-26-051493.md) | [449](/filings/0001104659-26-088136.md) |
| Total liabilities | $m | [362](/filings/0001558370-23-017247.md) | [348](/filings/0001558370-25-001382.md) | [308](/filings/0001558370-24-006387.md) | [409](/filings/0001558370-24-010484.md) | [388](/filings/0001558370-24-013946.md) | [388](/filings/0001104659-26-019108.md) | [371](/filings/0001558370-25-005995.md) | [384](/filings/0001558370-25-009797.md) | [403](/filings/0001104659-25-103731.md) | [441](/filings/0001104659-26-088136.md) | [503](/filings/0001104659-26-051493.md) | [475](/filings/0001104659-26-088136.md) |
| Shareholders' equity | $m | [819](/filings/0001558370-24-013946.md) | [841](/filings/0001104659-26-019108.md) | [853](/filings/0001558370-25-009797.md) | [875](/filings/0001104659-25-103731.md) | [897](/filings/0001104659-25-103731.md) | [911](/filings/0001104659-26-088136.md) | [877](/filings/0001104659-26-088136.md) | [885](/filings/0001104659-26-088136.md) | [903](/filings/0001104659-25-103731.md) | [910](/filings/0001104659-26-088136.md) | [922](/filings/0001104659-26-088136.md) | [953](/filings/0001104659-26-088136.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [50.2 d](/filings/0001558370-24-013946.md) | [12.3 d](/filings/0001104659-26-019108.md) | [57.3](/filings/0001558370-25-005995.md) | [38.4 d](/filings/0001558370-25-009797.md) | [52.9 d](/filings/0001104659-25-103731.md) | [25.2 d](/filings/0001104659-26-019108.md) | [(52.4)](/filings/0001104659-26-051493.md) | [26.3 d](/filings/0001104659-26-088136.md) | [64.1 d](/filings/0001104659-25-103731.md) | [27.4 d](/filings/0001104659-26-019108.md) | [14.3](/filings/0001104659-26-051493.md) | [(63.8) d](/filings/0001104659-26-088136.md) |
| Capital expenditure | $m | [2.5 d](/filings/0001558370-24-013946.md) | [2.2 d](/filings/0001104659-26-019108.md) | [1.6](/filings/0001558370-25-005995.md) | [1.8 d](/filings/0001558370-25-009797.md) | [1.8 d](/filings/0001104659-25-103731.md) | [2.4 d](/filings/0001104659-26-019108.md) | [1.7](/filings/0001104659-26-051493.md) | [1.6 d](/filings/0001104659-26-088136.md) | [1.9 d](/filings/0001104659-25-103731.md) | [2.2 d](/filings/0001104659-26-019108.md) | [2.0](/filings/0001104659-26-051493.md) | [1.9 d](/filings/0001104659-26-088136.md) |
| Dividends paid | $m | [2.1 d](/filings/0001558370-24-013946.md) | [2.1 d](/filings/0001104659-26-019108.md) | [2.6](/filings/0001558370-25-005995.md) | [2.6 d](/filings/0001558370-25-009797.md) | [2.6 d](/filings/0001104659-25-103731.md) | [2.6 d](/filings/0001104659-26-019108.md) | [3.9](/filings/0001104659-26-051493.md) | [3.8 d](/filings/0001104659-26-088136.md) | [3.8 d](/filings/0001104659-25-103731.md) | [3.8 d](/filings/0001104659-26-019108.md) | [5.0](/filings/0001104659-26-051493.md) | [5.0 d](/filings/0001104659-26-088136.md) |
| Share repurchases | $m | [0.0 d](/filings/0001558370-24-013946.md) | [0.0 d](/filings/0001104659-26-019108.md) | [0.2](/filings/0001558370-25-005995.md) | [3.4 d](/filings/0001558370-25-009797.md) | [4.1 d](/filings/0001104659-25-103731.md) | [4.6 d](/filings/0001104659-26-019108.md) | [43.7](/filings/0001104659-26-051493.md) | [16.7 d](/filings/0001104659-26-088136.md) | [5.1 d](/filings/0001104659-25-103731.md) | [10.7 d](/filings/0001104659-26-019108.md) | [2.5](/filings/0001104659-26-051493.md) | [0.0 d](/filings/0001104659-26-088136.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [26.5](/filings/0001558370-23-017247.md) | [26.4](/filings/0001558370-24-006387.md) | [26.4](/filings/0001558370-24-010484.md) | [26.4](/filings/0001558370-24-013946.md) | [26.5](/filings/0001558370-25-005995.md) | [26.5](/filings/0001558370-25-009797.md) | [26.5](/filings/0001104659-25-103731.md) | [26.2](/filings/0001104659-26-051493.md) | [25.5](/filings/0001104659-26-088136.md) | [25.5](/filings/0001104659-25-103731.md) | [25.3](/filings/0001104659-26-051493.md) | [25.3](/filings/0001104659-26-088136.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 25,238,099 at 2026-07-22, from the cover of the [10-Q filed 2026-07-29](/filings/0001104659-26-088136.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.